Keipert syndrome

Keipert syndrome, also known as nasodigitoacoustic syndrome, is an extremely rare genetic disorder characterized by a distinctive combination of craniofacial abnormalities, digital anomalies, and sensorineural hearing loss. The condition was first described by Keipert and colleagues in 1973. Key craniofacial features include a broad nasal bridge, a wide and prominent nose, widely spaced eyes (hypertelorism), and a short philtrum. Digital anomalies typically involve broad thumbs and great toes, as well as brachydactyly (shortened fingers and toes) with broad distal phalanges. Sensorineural hearing loss of variable severity is a hallmark feature and can significantly impact speech and language development if not identified and managed early. The syndrome primarily affects the skeletal system (particularly the hands and feet), the craniofacial structures, and the auditory system. Some affected individuals may also exhibit mild intellectual disability or developmental delay, though cognitive function can be normal. Additional features reported in some cases include short stature and other minor skeletal anomalies. There is currently no cure or disease-specific treatment for Keipert syndrome. Management is supportive and symptom-based, focusing on early audiological assessment and hearing aids or other amplification devices for hearing loss, speech therapy, and developmental support as needed. Orthopedic evaluation may be warranted for significant digital anomalies. Regular follow-up with a multidisciplinary team including genetics, audiology, and developmental specialists is recommended to optimize outcomes for affected individuals.

Common questions about Keipert syndrome